We are live on ! Find out more
PMC

PharMerica Corporation
PMC

Delisted

PMC was delisted on the 7th of December, 2017.

172 hedge funds and large institutions have $954M invested in PharMerica Corporation in 2015 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 61 increasing their positions, 60 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

117% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 12

16% more capital invested

Capital invested by funds: $822M → $954M (+$132M)

9% more funds holding

Funds holding: 158172 (+14)

2% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 60

Holders
172
Holders Change
+14
Holders Change %
+8.86%
% of All Funds
4.63%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
26
Increased
61
Reduced
60
Closed
12
Calls
$254K
Puts
Net Calls
+$254K
Net Calls Change
+$448K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$11.5M +$488K +15,900 +5%
Northern Trust
27
Northern Trust
Illinois
$11.4M -$231K -7,510 -2%
Millennium Management
28
Millennium Management
New York
$10.8M -$312K -10,173 -3%
SGCIA
29
Smith Graham & Co Investment Advisors
Texas
$10.7M -$4.38M -142,531 -31%
Wells Fargo
30
Wells Fargo
California
$8.72M +$2.67M +86,836 +50%
HCMT
31
Highland Capital Management (Texas)
Texas
$8.54M -$1.91M -62,211 -20%
PCA
32
Personal Capital Advisors
California
$7.99M +$743K +24,215 +11%
PFC
33
Phocas Financial Corp
California
$7.87M +$2.27M +73,834 +45%
Boston Partners
34
Boston Partners
Massachusetts
$7.73M +$2.29M +74,710 +47%
SAM
35
Senzar Asset Management
New York
$7.63M -$1.46M -47,500 -17%
Invesco
36
Invesco
Georgia
$6.94M +$1.87M +60,980 +41%
Adage Capital Partners
37
Adage Capital Partners
Massachusetts
$6.66M -$3.07M -100,000 -33%
HA
38
Heartland Advisors
Wisconsin
$6.66M
Geode Capital Management
39
Geode Capital Management
Massachusetts
$6.29M -$599K -19,499 -9%
OCG
40
Opus Capital Group
Ohio
$6.24M -$77.4K -2,522 -1%
Principal Financial Group
41
Principal Financial Group
Iowa
$6.16M -$53.1K -1,731 -0.9%
Charles Schwab
42
Charles Schwab
California
$5.85M +$735K +23,939 +16%
PPA
43
Parametric Portfolio Associates
Washington
$5.73M -$1.35M -43,983 -20%
TCIM
44
TIAA CREF Investment Management
New York
$5.66M +$616K +20,073 +13%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$5.18M -$1.44M -47,043 -23%
Two Sigma Investments
46
Two Sigma Investments
New York
$5.13M +$1.3M +42,231 +38%
AQR Capital Management
47
AQR Capital Management
Connecticut
$5.12M -$3.42M -111,293 -42%
BCM
48
Bridgeway Capital Management
Texas
$4.89M
GL
49
GLG LLC
New York
$4.62M +$4.26M +138,840 New
GP
50
GLG Partners
United Kingdom
$4.38M +$902K +29,380 +29%

PMC Hedge Fund Activity: Q2 2015 in Review

172 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q2 2015, worth a combined $954M — up 16% from $822M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new PMC positions and 12 closed out — a net gain of 14 holders — while 61 added to existing stakes and 60 trimmed.

The largest buyer was Paulson & Co, opening a new position worth an estimated $15.3M. The largest seller was Chartwell Investment Partners, cutting an estimated $26.5M.

  • 172 institutional investors held PharMerica Corporation (PMC) as of Q2 2015, up from 158 in Q1 2015.
  • Funds reported $954M of PharMerica Corporation stock for Q2 2015, up 16% quarter-over-quarter.
  • 26 funds opened new PharMerica Corporation positions in Q2 2015 and 12 closed out, a net change of +14 holders.
  • The largest PharMerica Corporation buyer in Q2 2015 was Paulson & Co, an estimated $15.3M added.
  • The largest PharMerica Corporation seller in Q2 2015 was Chartwell Investment Partners, an estimated $26.5M sold.

Based on aggregated 13F filings for Q2 2015.